Back to search
FDAFDA · Food and drugs·Recall number D-0967-2020

Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3

Published March 11, 2020 · Recall initiated: January 15, 2020

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Press Release

Recall details

Manufacturer
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Distributor
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Lot
Lot #: 07232019+52730, Exp 1/19/2020; 07232019+52732, Exp 1/19/2020; 07242019+52748, Exp 1/20/2020; 11212019+53272, Exp 5/19/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card